Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

MS and cognition and APOE: the ongoing conundrum about biomarkers.

Sadovnick AD, Jacobs DH.

Neurology. 2008 Jan 15;70(3):164-5. doi: 10.1212/01.wnl.0000297938.22145.a7. No abstract available.

PMID:
18195261
2.

APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.

Shi J, Zhao CB, Vollmer TL, Tyry TM, Kuniyoshi SM.

Neurology. 2008 Jan 15;70(3):185-90. Epub 2007 Apr 25.

PMID:
17460153
3.

Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.

Guerrero AL, Laherrán E, Gutiérrez F, Martín-Polo J, Iglesias F, Alcázar C, Peralta J, Rostami P.

Acta Neurol Scand. 2008 Jan;117(1):21-5. Epub 2007 Sep 19.

PMID:
17883422
4.

The effect of APOE genotype on clinical phenotype in Alzheimer disease.

Borroni B, Di Luca M, Padovani A.

Neurology. 2007 Feb 20;68(8):624; author reply 624. No abstract available.

PMID:
17310043
5.

APOE epsilon4 is associated with impaired verbal learning in patients with MS.

Koutsis G, Panas M, Giogkaraki E, Potagas C, Karadima G, Sfagos C, Vassilopoulos D.

Neurology. 2007 Feb 20;68(8):546-9.

PMID:
17310023
6.

The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction.

Gromadzka G, Baranska-Gieruszczak M, Sarzynska-Dlugosz I, Ciesielska A, Czlonkowska A.

Acta Neurol Scand. 2007 Dec;116(6):392-8.

PMID:
17986098
7.

Impact of apolipoprotein gene on cognitive impairment and recovery after traumatic brain injury.

Ponsford J, Rudzki D, Bailey K, Ng KT.

Neurology. 2007 Feb 20;68(8):619-20. No abstract available.

PMID:
17310037
8.

APOE genotypes in African American female multiple sclerosis patients.

Huang R, Hughes M, Mobley S, Lanham I, Poduslo SE.

Neurosci Lett. 2007 Feb 27;414(1):51-6. Epub 2007 Jan 7.

PMID:
17254710
9.

The telltale scan: APOE epsilon4 in multiple sclerosis.

Masterman T, Hillert J.

Lancet Neurol. 2004 Jun;3(6):331. Review. No abstract available.

PMID:
15157846
10.

Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.

O'Hara R, Schröder CM, Kraemer HC, Kryla N, Cao C, Miller E, Schatzberg AF, Yesavage JA, Murphy GM Jr.

Neurology. 2005 Aug 23;65(4):642-4.

PMID:
16116137
11.

Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults.

Pendleton N, Payton A, van den Boogerd EH, Holland F, Diggle P, Rabbitt PM, Horan MA, Worthington J, Ollier WE.

Neurosci Lett. 2002 May 10;324(1):74-6.

PMID:
11983298
12.

[Apolipoprotein E polymorphism as a predictor of progression of multiple sclerosis].

Guerrero AL, Bueno V, Hernández MT, Martín-Serradilla JI, Carrasco E, Cuadrado I.

Neurologia. 2003 Apr;18(3):146-8. Spanish.

PMID:
12677480
13.

Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease.

Camicioli R, Kryscio R.

Neurology. 2005 Dec 27;65(12):1855-6. No abstract available.

PMID:
16380605
14.

Apolipoprotein E4 and tau allele frequencies among Choctaw Indians.

Henderson JN, Crook R, Crook J, Hardy J, Onstead L, Carson-Henderson L, Mayer P, Parker B, Petersen R, Williams B.

Neurosci Lett. 2002 May 10;324(1):77-9.

PMID:
11983299
15.

APOE and risk of cognitive impairment in multiple sclerosis.

Oliveri RL, Cittadella R, Sibilia G, Manna I, Valentino P, Gambardella A, Aguglia U, Zappia M, Romeo N, Andreoli V, Bono F, Caracciolo M, Quattrone A.

Acta Neurol Scand. 1999 Nov;100(5):290-5.

PMID:
10536914
16.

APOE genotype is a major predictor of long-term progression of disability in MS.

Becker KG.

Neurology. 2001 Dec 11;57(11):2148-9. No abstract available.

PMID:
11739852
17.

APOE epsilon4 allele is associated with cognitive impairment in patients with multiple sclerosis.

Mazurek AA, Shi J.

Neurology. 2008 Oct 7;71(15):1203; author reply 1203. doi: 10.1212/01.wnl.0000334492.19068.3e. No abstract available.

PMID:
18838671
18.

APOE epsilon4 and the cognitive genetics of multiple sclerosis.

Ghaffar O, Reis M, Pennell N, O'Connor P, Feinstein A.

Neurology. 2010 May 18;74(20):1611-8. doi: 10.1212/WNL.0b013e3181e074a7.

19.

Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.

van der Walt A, Stankovich J, Bahlo M, Taylor BV, van der Mei IA, Foote SJ, Kilpatrick TJ, Rubio JP, Butzkueven H.

Neurology. 2009 Sep 29;73(13):1018-25. doi: 10.1212/WNL.0b013e3181b9c85e.

PMID:
19786693
20.

ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study.

Louko AM, Vilkki J, Niskakangas T.

Acta Neurol Scand. 2006 Nov;114(5):315-9.

PMID:
17022778

Supplemental Content

Support Center